GILD

Gilead Sciences, Inc. News Headlines

$102.4
*  
1.94
1.93%
Get GILD Alerts
*Delayed - data as of Dec. 17, 2014  -  Find a broker to begin trading GILD now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks
Viewing
Filtered By
Ordered By
A Practical Approach To Tech Investing
12/4/2014 9:00:00 AM - Seeking Alpha


Johnson & Johnson Bought Alios for Hepatitis C
12/4/2014 8:21:02 AM - Motley Fool


Cramer's Mad Money - PVH Fits Well At A Discount (12/3/14)
12/4/2014 6:04:00 AM - Seeking Alpha


Third Quarter Earnings Season In Review: Sector Winners And Losers, The Misleading 'Record' Beat Rate And The Outlook For Q4
12/3/2014 5:50:00 PM - Seeking Alpha


Mylan, Gilead Ink Deal for TAF-based HIV Drugs - Analyst Blog
12/2/2014 5:45:00 PM - Zacks.com


An Update For Gilead Sciences
12/2/2014 4:32:00 PM - Seeking Alpha


Gilead Set To Trounce AbbVie's HCV Combo
12/2/2014 11:29:00 AM - Seeking Alpha


The Most Important FDA Decision We're Watching This Month
12/2/2014 9:00:03 AM - Motley Fool


PDL BioPharma, Inc. (PDLI) Ex-Dividend Date Scheduled for December 03, 2014
12/2/2014 9:00:01 AM - NASDAQ.com News


Why Gilead Sciences, Inc. Stock Lost 10% in November
12/2/2014 8:06:02 AM - Motley Fool


Sovaldi Versus Abbvie Combination: Analysis Of Abbvie Combination Impact On Sovaldi Market Share
12/2/2014 8:05:00 AM - Seeking Alpha


Nasdaq 100 Movers: VIP, GILD
12/1/2014 11:50:32 AM - BNK Invest


3 Healthcare Stocks to Hold Forever
12/1/2014 11:45:02 AM - Motley Fool


Mylan Signs Deal With Gilead To Enhance Access To TAF-based HIV Treatments
12/1/2014 8:57:00 AM - RTT News


Bristol-Myers Squibb Co's Hep C Drug Denied; Gilead Sciences Inc. Smiling (for Now)
11/29/2014 3:48:03 PM - Motley Fool


5 Drug Classes Where Prescription Spending Could Grow the Quickest
11/29/2014 2:23:03 PM - Motley Fool


Gilead Sciences - Investigating Earnings Predictability
11/29/2014 8:29:00 AM - Seeking Alpha


Gilead Sciences: Is Gilead Taking The Lead? - A Bullish Fundamental & Algorithmic Perspective
11/28/2014 1:17:00 PM - Seeking Alpha


How Much Is The Biotech Industry Stretched?
11/28/2014 8:11:00 AM - Seeking Alpha


Johnson & Johnson's Rezolsta Approved in the EU for HIV-1 - Analyst Blog
11/27/2014 1:20:00 PM - Zacks.com


Should Gilead Sciences, Inc. Pay a Dividend?
11/26/2014 9:15:03 AM - Motley Fool


For Gilead, Are Products More Important Than Price?
11/25/2014 2:16:00 PM - Seeking Alpha


3 Simple Reasons Doctors May Stick With Gilead Sciences Instead of AbbVie
11/25/2014 11:38:02 AM - Motley Fool


Despite Recent Hiccup, Gilead Is Still A Blue Chip Gem
11/25/2014 10:43:00 AM - Seeking Alpha


Why You Shouldn't Bet Against Gilead Sciences (GILD) Stock - Tale of the Tape
11/25/2014 8:59:00 AM - Zacks.com